Jeffrey Abbott is a Co-founder and CEO of CytoTronics. He is an engineer, scientist, and entrepreneur, holding a BS and MS in analog integrated circuit design from Rochester Institute of Technology, a Ph.D. in Engineering Sciences from Harvard's School of Engineering and Applied Sciences, and has conducted postdoctoral research in Chemistry and Chemical Biology at Harvard. Jeffrey’s early research focused on CMOS integrated circuits, which he later expanded into bioelectronics, merging electrical engineering with biology to develop tools for advanced cell-based assays. Today, he leads CytoTronics’ mission to deliver high-throughput, real-time analysis platforms that empower researchers to uncover new insights in drug discovery and biomedical research.